Stock Events

Stock Events

Scandinavian Real Heart AB. 

SEK13.55
0
+SEK0.55+4.23%Monday 11:33

Statistics

Day High
13.55
Day Low
13.55
52W High
19
52W Low
13
Volume
120
Avg. Volume
695
Mkt Cap
115.15M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-35.5MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Edwards Lifesciences
EW
Mkt Cap53.03B
Edwards Lifesciences specializes in artificial heart valves, directly competing in the cardiac device market.
Medtronic
MDT
Mkt Cap123.49B
Medtronic offers a range of cardiac products, including mechanical circulatory support, competing in the same space as Real Heart.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories provides various cardiac devices, including ventricular assist devices, overlapping with Real Heart's offerings.
Stryker
SYK
Mkt Cap111.95B
Stryker Corporation, known for medical devices, has ventured into cardiac solutions that could compete with artificial heart technologies.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific is involved in developing and marketing cardiac devices, which places them in competition with Real Heart.
Baxter International
BAX
Mkt Cap11.9B
Baxter International operates in the bio-surgical products including devices that support cardiac health, competing with Real Heart.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet, while primarily focused on orthopedics, has shown interest in expanding to other medical devices that could include cardiac solutions.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson's medical devices segment includes products for cardiovascular care, potentially competing with Real Heart.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical develops robotic-assisted surgical systems, which could be adapted for use in cardiac surgeries, indirectly competing with Real Heart.
Globus Medical
GMED
Mkt Cap10.48B
Globus Medical, primarily focused on spine, could move into cardiac devices, posing future competition to Real Heart.

About

Scandinavian Real Heart AB (Publ), a Swedish enterprise established in 2007, specializes in the innovation and production of artificial heart devices. The company's core focus is the Realheart TAH, a total artificial heart engineered specifically to address severe cases of heart failure. Beyond this central project, their product portfolio also encompasses medical solutions such as the RealVAD, PulsePump, and Sternal Prosthesis. The firm operates from its base in Västerås, Sweden.
Show More
CEO
Ina Laura Perkins
Employees
18
Country
Sweden
ISIN
SE0026876633

Listings

F
DE
7820.F
ST
SE
HEART-BT-UN.ST
ST
SE
HEART.ST
ST
SE
HEART-BTA.ST

0 Comments

Share your thoughts

FAQs

What is Scandinavian Real Heart AB. stock price today?▼
The current price of HEART-BTA.ST is SEK13.55 SEK — it has increased by +4.23% in the past 24 hours. Watch Scandinavian Real Heart AB. stock price performance more closely on the chart.
What is Scandinavian Real Heart AB. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Scandinavian Real Heart AB. stocks are traded under the ticker HEART-BTA.ST.
What is Scandinavian Real Heart AB. market cap?▼
Today Scandinavian Real Heart AB. has the market capitalization of 115.15M
What is Scandinavian Real Heart AB. revenue for the last year?▼
Scandinavian Real Heart AB. revenue for the last year amounts to 0 SEK.
What is Scandinavian Real Heart AB. net income for the last year?▼
HEART-BTA.ST net income for the last year is -35.5M SEK.
How many employees does Scandinavian Real Heart AB. have?▼
As of November 2, 2026, the company has 18 employees.
In which sector is Scandinavian Real Heart AB. located?▼
Scandinavian Real Heart AB. operates in the Health & Wellness sector.
When did Scandinavian Real Heart AB. complete a stock split?▼
Scandinavian Real Heart AB. has not had any recent stock splits.
Where is Scandinavian Real Heart AB. headquartered?▼
Scandinavian Real Heart AB. is headquartered in Västerås, Sweden.